Covaxin to cost Rs 1,200 per dose for private hospitals, Rs 600 for states
Bharat Biotech noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D
)
Explore Business Standard
Bharat Biotech noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D
)
Already subscribed? Log in
Subscribe to read the full story →
3 Months
₹300/Month
1 Year
₹225/Month
2 Years
₹162/Month
Renews automatically, cancel anytime
Over 30 premium stories daily, handpicked by our editors


News, Games, Cooking, Audio, Wirecutter & The Athletic
Digital replica of our daily newspaper — with options to read, save, and share


Insights on markets, finance, politics, tech, and more delivered to your inbox
In-depth market analysis & insights with access to The Smart Investor


Repository of articles and publications dating back to 1997
Uninterrupted reading experience with no advertisements


Access Business Standard across devices — mobile, tablet, or PC, via web or app
First Published: Apr 24 2021 | 10:52 PM IST